Unknown OBSERVATIONAL NCT03941210

Micro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected Patients (miRNA)

Sponsor: ANRS, Emerging Infectious Diseases

Conditions HIV Infection Tuberculosis Infection

Interventions Detection of molecular Biomarkers

Updated 9 times since 2019 Last updated: Jan 6, 2020 Started: Mar 1, 2018 Primary completion: Mar 1, 2020 Completion: Mar 1, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03941210, this observational or N/A phase trial focuses on HIV Infection and Tuberculosis Infection and remains ongoing. Sponsored by ANRS, Emerging Infectious Diseases, it has been updated 9 times since 2018, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2022 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Dec 2021 — Jan 2022 [monthly]

Recruiting
Oct 2021 — Dec 2021 [monthly]

Recruiting

▶ Show 4 earlier versions

Jan 2021 — Oct 2021 [monthly]

Recruiting
Nov 2020 — Jan 2021 [monthly]

Recruiting
Feb 2020 — Nov 2020 [monthly]

Recruiting
Jun 2019 — Feb 2020 [monthly]

Recruiting

First recorded

Mar 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ANRS, Emerging Infectious Diseases

Data source: ANRS, Emerging Infectious Diseases

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Phnom Penh, Cambodia